Mpox

Orphan designation: idebenone Treatment of Leber's hereditary optic neuropathy, 16/02/2007 Expired

Orphan designation: Panobinostat Treatment of multiple myeloma, 08/11/2012 Expired

LinkedIn Live: Smarter trials, stronger Europe. New targets for clinical research., European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2025, 14:00 (CEST) to 24 September 2025, 15:00 (CEST)

Human Medicines

Organisation chart: Human Medicines

Human medicines European public assessment report (EPAR): Baqsimi, glucagon, Date of authorisation: 16/12/2019, Revision: 6, Status: Authorised

Committee for Advanced Therapies (CAT) workshop on gene editing, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 September 2025, 10:00 (CEST) to 16 September 2025, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Emselex, darifenacin hydrobromide, Date of authorisation: 22/10/2004, Revision: 28, Status: Authorised

Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025, European Medicines Agency, Amsterdam, the Netherlands, from 15 September 2025 to 18 September 2025